Abstract: The vacuolar ATPase (V-ATPase; V 1 V o -ATPase) is a large multisubunit proton pump found in the endomembrane system of all eukaryotic cells where it acidifies the lumen of subcellular organelles including lysosomes, endosomes, the Golgi apparatus, and clathrin-coated vesicles. V-ATPase function is essential for pH and ion homeostasis, protein trafficking, endocytosis, mechanistic target of rapamycin (mTOR), and Notch signaling, as well as hormone secretion and neurotransmitter release. V-ATPase can also be found in the plasma membrane of polarized animal cells where its proton pumping function is involved in bone remodeling, urine acidification, and sperm maturation. Aberrant (hypo or hyper) activity has been associated with numerous human diseases and the V-ATPase has therefore been recognized as a potential drug target. Recent progress with moderate to high-resolution structure determination by cryo electron microscopy and X-ray crystallography together with sophisticated single-molecule and biochemical experiments have provided a detailed picture of the structure and unique mode of regulation of the V-ATPase. This review summarizes the recent advances, focusing on the structural and biophysical aspects of the field.
Introduction
The vacuolar H 1 -ATPase (V-ATPase, V 1 V o -ATPase) is a ubiquitous multisubunit enzyme complex that acidifies subcellular compartments in all eukaryotic cells and the extracellular space in some specialized tissues of higher organisms. [1] [2] [3] [4] V-ATPase's proton pumping activity plays a vital role in numerous essential cellular processes such as pH and ion homeostasis, protein trafficking, autophagy, endocytosis, mTOR, and Notch signaling, as well as bone remodeling, urine acidification, hormone secretion, and neurotransmitter release. [5] [6] [7] [8] [9] While complete loss of V-ATPase function However, identifying and optimizing drugs that are designed to modulate V-ATPase activity rather than causing complete inhibition will require a detailed understanding of the enzyme's structure and its catalytic and regulatory mechanisms. V-ATPase is made up of $14 unique subunits that are present in different stoichiometries, resulting in $30 polypeptides with a total relative molar mass of close to one million. The complex can be divided into two functional sectors, a water soluble ATP hydrolyzing catalytic V 1 made of subunits A-H, and a membrane embedded V o proton channel composed of subunits a,d,e,f, and two to three "proteolipid" isoforms referred to as subunits c, (c 0 ), and c 00 [ Fig. 1(A) ]. While V-ATPases from higher organisms can contain additional components such as Ac45 (ATP6AP1) or (pro)renin receptor (ATP6AP2), the core V-ATPase complex is highly conserved from simple eukaryotes (such as baker's yeast) to higher animals, including human. Most of the subunits in higher organisms are expressed as multiple isoforms, some of which are organelle or tissue specific. 24 However, in yeast only subunit a is expressed as two isoforms, with isoform Vph1p found in the vacuole and Stv1p in the Golgi. 25 The well-defined subunit composition, together with the ease of genetic manipulation, has made yeast a powerful model system for structural and mechanistic studies of intact V-ATPase and its V 1 and V o sectors isolated from the native source. The composition of the V-ATPase from the yeast Saccharomyces cerevisiae is A 3 B 3 (C)DE 3 FG 3 H for the V 1 and a,c 8 ,c 0 ,c 00 ,d,e,f for the V o [ Fig. 1(A) ]. Subunit f was only very recently found associated with yeast V o , 26 but since deletion of the corresponding gene did not produce the well characterized deletion phenotype, 27 its designation as a V-ATPase subunit requires further study. V-ATPase is a molecular motor enzyme, employing a rotary mechanism of energy coupling that is shared with the related F-, A-, and A/V-type ATPases/ ATP synthases. [28] [29] [30] In the V-ATPase, stepwise rotation of a central rotor domain made of V 1 subunits DF and V o subunits d and c couples the energy of ATP hydrolysis released from three catalytic sites on V 1 to the uphill transport of protons across the lipid bilayer. However, unlike the related rotary motor ATPases, V-ATPase activity in vivo is regulated via a unique mechanism referred to as "reversible dissociation" (or disassembly), a process that results in a transient pool of free cytosolic V 1 and membrane integral V o sectors that are functionally silenced [ Fig. 1(B) ]. V-ATPase regulation by reversible dissociation was initially discovered in yeast 31 and insect 32 but more recent studies show that the process is conserved in higher animals including human. 6, [33] [34] [35] This short review summarizes recent insights into the V-ATPase's unique mode of regulation by reversible disassembly, focusing on the structural aspects of the process. Considering recent progress with structure determination of the autoinhibited V 1 and V o sectors from yeast, a model of the molecular mechanism of V-ATPase disassembly is proposed. The review is concluded by a summary of some of the unresolved questions in the field.
V-ATPase Structure
Throughout this review, V-ATPase will refer to the eukaryotic enzyme unless stated otherwise. Where appropriate, the eukaryotic V-ATPase from the yeast S. cerevisiae and its functional sectors will be designated by the prefix "Sc" as in ScV 1 V o , ScV 1 , and ScV o . In analogy, the bacterial enzyme (from e.g. Enterococcus hirae) will be written as EhV 1 V o , EhV 1 , and EhV o . By convention, subunits of the catalytic and membrane sectors will be in capital letters (ABCDEFGH) and lower case italics (acc'c"def), respectively.
The structures of the holo V-ATPase and its two separated sectors have been studied extensively using negative stain and cryo electron microscopy (cryoEM) together with single-particle image averaging and three-dimensional (3-D) volume reconstruction. Early on, tagging of the enzyme with subunit specific probes such as monoclonal antibodies helped to elucidate the overall subunit arrangement and stoichiometry. At the same time, crystal structures of individual subunits or subunit complexes of yeast V-ATPase (subunits H, C, and EG), and subcomplexes from related bacterial enzymes such as the sodium pumping V-like ATPase from E. hirae (EhV 1 V o ) and the A-ATPase from Thermus thermophilus (TtA 1 A o ) were becoming available. Fitting of the crystal structures into the low to mediumresolution EM maps allowed building of partial and eventually complete pseudo atomic models of the VATPase and its V 1 and V o sectors isolated from various sources including bovine brain, [36] [37] [38] insect midgut, 39 and yeast vacuoles. [40] [41] [42] [43] The early models not only confirmed the V-ATPase's structural similarity to the related F-ATP synthases, which was already evident from primary sequence analysis of the catalytic and proteolipid subunits, 44 but the EM models also revealed the increased complexity of the VATPase compared to its ATP synthase counterparts. Recently, advances in electron detector technology have allowed determination of cryoEM maps of insect and yeast V-ATPase at subnanometer resolution. 45, 46 These maps revealed secondary structure elements in both the soluble V 1 and, for the first time, in the membrane embedded V o . Together with the available crystal structures, the density maps allowed building of pseudo atomic models of the complex in different catalytic states.
Overall architecture of holo V-ATPase
The A and B subunits of V 1 come together in an alternating fashion to form a "catalytic hexamer" (A 3 B 3 ) with catalytic nucleotide binding sites located at three of the six AB interfaces 47 [ Fig. 2 [ Fig. 2(B) ]. Structural support between ATPase and proton channel is provided by the "peripheral stator", which consists of three heterodimers formed by subunits E and G ("peripheral stalks" EG1-3) [ Fig. 2(C,D) ], the single copy subunits H and C [ and foot and head domains for subunit C (C foot and C head ) 51 [ Fig. 2(F) ]. Subunit a of the V o can be divided into a cytosolic N-terminal (a NT ) and a membrane-integral C-terminal domain (a CT ). The a NT X-ray crystal structure of the related A-ATPase from M. ruber showed the protein to be folded in two domains designated as proximal and distal lobes (a NT(prox) and a NT(dist) ) 52 [ Fig four transmembrane a helices (TMH) except isoform c 00 , which has an additional a helix at its N-terminus that is not essential for function. 54 From sequence analysis it has been proposed that V-ATPase four TMH proteolipids have originated by gene duplication from ancestral two TMH c subunits found in F-and A-type motors. 55 As of today, there is no high-resolution crystal structure of eukaryotic holo V-ATPase or of any of its bacterial or archaeal counterparts. The highest resolution information currently available for the intact enzyme has been obtained by cryoEM of the yeast V-ATPase. were placed into the map, and the individual subunits' structures were flexibly fit guided by the cryoEM map density. Note that there is no highresolution structure available for the membrane embedded C-terminal domain of subunit a as part of holo V-ATPase (but see below for the recent 3.9 Å cryoEM map of autoinhibited ScV o ).
The V-ATPase in animal cells
The comparison of the early low-resolution EM studies of bovine brain V-ATPase 56 with images of the yeast enzyme 57, 58 showed that the basic architecture of the V-ATPase complex is conserved from lower eukaryotes to mammals. As mentioned above, in yeast only subunit a is expressed as two organelle specific isoforms, Vph1p and Stv1p. 25 Although subunits c, c 0 , and c 00 are sometimes called proteolipid isoforms, all three variants of the c subunits are essential for enzyme function in yeast 59 (as of today, c 0 has not been identified in higher animals). In the animal V-ATPase, on the other hand, most of the subunits are expressed as multiple isoforms, some of which are organelle or tissue specific. 24 Most notable shown). 49 (E) Crystal structure of ScH (1ho8). 50 (F) Crystal structure of ScC (1u7l). 51 (G) Crystal structure of the a NT homolog from M. ruber (Mra; 3rrk). 52 (H) Crystal structure of the d homolog from T. thermophilus (TtC; 1r5z). 103 (I) Crystal structure of the proteolipid ring from E. hirae (EhK10; 2bl2) 53 . (J) CryoEM map of ScV 1 V o (emd-6284) 45 with fitted coordinate models of individual subunits and subcomplexes (3j9t). 45 The overall model was generated from individual crystal structures of yeast subunits and homology models generated by threading yeast primary sequences into crystal structures of bacterial A-ATPase subunits.
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are the four isoforms of subunit a with isoform a 1 found in neurons, a 2 in endothelia, a 3 in osteoclast ruffled membrane and pancreatic b cells, and a 4 in the kidney. However, isoform distribution is not strictly defined, making it very challenging, if not impossible, to isolate and purify animal V-ATPases with a homogeneous isoform composition.
V-ATPase Mechanism
The V-ATPase, like all members of the rotary ATPase family, contains two motors: a V 1 motor that converts the chemical energy of ATP hydrolysis into mechanical energy (torque of central DF rotor), and a V o proton turbine that converts mechanical energy into the potential energy store of an ion gradient [28] [29] [30] [ Fig. 3(A) ]. Conformational changes powered by ATP hydrolysis at the three catalytic sites on the A 3 B 3 hexamer drive rotation of the central DF rotor [ Fig. 3(B) ], which in turn, via its connection to subunit d, rotates the c-ring past the membrane integral a CT for proton translocation across the lipid bilayer [ Fig. 3(C) ]. During catalysis, the three peripheral stalks (EG1-3), in conjunction with subunits C, H, and a NT , function to resist the torque of rotation, thus keeping the A 3 B 3 hexamer static against the proton channel to allow for the rotation to be productive [ Fig. 3(A) ]. From biochemical and biophysical work on related bacterial enzymes, we have some understanding of the molecular mechanism of ATP hydrolysis and the concomitant conformational changes on the A 3 B 3 catalytic hexamer that drive rotation of the central DF rotor. For each ATP hydrolyzed, the central rotor rotates 120 counter-clockwise (when looking towards the cytoplasm), driven by conformational changes that occur in the A 3 B 3 hexamer upon ATP binding, hydrolysis, and product release. Interestingly, while in F-ATP synthase each 120 rotation occurs in substeps of $80
(ATP binding/release) and 40 (ADP/Pi binding/release), 60 no substeps have been observed for bacterial V-like ATPase from, for example T. thermophilus 61 or E. hirae 62 as of today.
As previously mentioned, the central DF rotor, via its connection to subunit d, rotates the c-ring past the membrane integral a CT to pump protons across the lipid bilayer. Each c subunit contains an essential glutamic acid residue mid-membrane that, after getting protonated in an aqueous half channel accessible from the cytoplasmic side, is able to enter the lipid bilayer and following a close to 360 rotation of the c-ring, delivers its proton to an aqueous half-channel accessible from the lumen of the organelle or the outside of the cell [ Fig. 3(C) ]. A strictly conserved arginine residue in a CT located at the interface of a CT and the c-ring (Arg735 in yeast 63 ) serves to stabilize the essential glutamic acid residues of the c subunits while in the deprotonated state between lumen and cytoplasmic half channels. Besides the essential Arg735, site-directed mutagenesis experiments in yeast V-ATPase have uncovered several charged and polar residues in a CT that are essential for proton pumping. 64 How these residues work together to guide the protons from the cytoplasmic to the lumen or cellular exterior, however, is not known, largely because of lack of highresolution structural information for the V-ATPase's (or, for that matter, any of the rotary ATPases') membrane sector, as well as the dynamic nature of the process.
V-ATPase Regulation
Breaking up. . .
V-ATPase hydrolyzes up to $300 ATPÁ(sec 21 ) 65 and as a major consumer of cellular energy ‡ , its MgATPase activity must be tightly controlled. In eukaryotic organisms, the enzyme's proton pumping activity is regulated by reversible dissociation (or disassembly), a process resulting in free, water soluble cytoplasmic ATPase (V 1 ) and membrane bound proton channel (V o ) sectors. In yeast, reversible dissociation is driven by environmental factors such as nutrient availability, 31, 32 salinity, 66 and extracellular pH. 67 In higher animals, reversible disassembly or stimulated assembly (without prior disassembly) occurs in response to nutrients, 33, 35 cell maturation, 34 hormones, 68 and growth factors. 6 Upon enzyme dissociation, the activity of both sectors is silenced, resulting in a V 1 that has no MgATPase activity [69] [70] [71] and a V o that does not catalyze passive proton translocation. 72, 73 From studies in yeast and insect, we have some information as to the molecular mechanism of regulated disassembly. Upon initiating disassembly by, for example glucose withdrawal in yeast, the C subunit dissociates from the vacuolar membrane 31 and is not part of either V 1 or V o when these complexes are purified subsequent to enzyme disassembly. 40, 69, 70, 73 It is also known that inhibition of ATP hydrolysis by, for example mutation of residues involved in catalysis, nucleotide binding, or proton transport, or by binding of specific drugs that block rotation, results in "hyper-assembly", 74, 75 which indicates that disassembly occurs while the enzyme is in a high-energy conformation during rotary catalysis. MgADP inhibited state is an off-catalytic pathway conformation that is also found in other related rotary ATPase catalytic sectors. 83 The role of subunit H in activity silencing has recently been illuminated in the 6. Fig. 4(A) ]. The structural and accompanying biochemical studies also showed that while V 1 DH contained only $0.4 moles/mol ADP, autoinhibited ScV 1 Upon release of V 1 -ATPase from the membrane, the N-terminus of subunit a (a NT ) moves from its ternary interface with C foot and EG2 to form a new binding interface with subunit d 26, 73, 88 and the c-ring is positioned so that Glu108 of isoform c 00 is in contact with the essential Arg735 in a CT .
proteolipid isoforms referred to as subunit c, c 0 , and c 00 . As mentioned above, the c and c 0 proteolipid isoforms have each four TMH while the c 00 isoform has five. It was noted that while the essential glutamic acid residues in c and c 0 are in TM helix 4 (Glu137 and Glu145, respectively), the corresponding residue in c 00 is in helix 3 (Glu108). 59 This led to the speculation that the resulting asymmetry in the spacing of the proton transporting glutamic acid residues at the periphery of the c-ring may be the cause of autoinhibition as the large gap in carboxyls at the interface of c 00 and c 0 might not be able to move past a CT 's Arg735, thereby preventing the reversal of the direction of rotation that would be required for passive proton transport. 73 Recently, Mazhab-Jafari et al.
reported a cryoEM reconstruction of autoinhibited ScV o , allowing a first glimpse at the interactions between residues of the a CT stator and the c-ring rotor within the membrane 26 [ Fig. 4(C) ]. As first seen in the related F-ATP synthase from Polytomella sp., 87 a CT contains two long a helices that cross the lipid bilayer at an angle of 30 with respect to the plane of the membrane and contact the periphery of the c-ring mid-membrane. In V-ATPase, these two a helices contain some of the charged and polar residues identified in the site-directed mutagenesis experiments mentioned above, 64 including the essential Arg735. While the EM model of the autoinhibited ScV o showed a cavity on the cytoplasmic side likely to represent the aqueous access for protons to enter the membrane before they bind the glutamates on the proteolipids, no such cavity was identified on the lumenal side of the complex. 26 The cryoEM model of autoinhibited yeast V o also confirmed the earlier proposal in that Glu108 of c 00 was seen to be in contact with Arg735 26 [ Fig. 4(C) ]. However, whether the asymmetry in the glutamic acid spacing is the sole reason for V o 's autoinhibition remains to be seen.
. . . and making up
The comparison between ScV 1 and holo ScV 1 V o mentioned above also revealed that subunit H and MgADP facilitated autoinhibition halts ScV 1 in state 2 based on the position of the central DF rotor 71 [ Fig. 4(A,B) ]. The corresponding comparison of the ScV o sectors based on the position of the proteolipid ring or the d subunit showed that autoinhibited ScV o is arrested in state 3. 26, 88 These observations lead to the proposal that the resulting mismatch between state 2 V 1 and state 3 V o conformations may serve to prevent unintended reassembly of the complex when its proton pumping activity is not required. 88 Consequently, before reassembly can take place, the conformational mismatch must be overcome. Bringing V 1 and V o into matching rotational states can either happen by converting V o from state 3 to state 2 or by converting V 1 from state 2 to state 3. Since autoinhibited V o is arrested in state 3 despite a transmembrane proton gradient, it is more likely that subunit H stabilized MgADP inhibition of V 1 is relieved to allow hydrolysis of at least one ATP molecule with concomitant rotation of the central rotor from state 2 to state 3 to match V o 's rotational state. What could be the mechanism for relieving the ADP inhibition? From studies in yeast, it is known that assembly, be it the initial assembly following biosynthesis, or the re-assembly following reversible disassembly, occurs in absence of turnover but requires presence of the "regulator of H 1 -ATPases of vacuolar and endosomal membranes" (RAVE), 89 ,90 a heterotrimeric chaperone complex that has been shown to promote assembly by binding to the V 1 , the V o , and the C subunit. 91, 92 Curiously, for reasons that are currently not understood, the RAVE complex seems not to be required for the assembly of Stv1 containing V-ATPase found in the Golgi. 93 Besides the RAVE complex, several enzymes of the glycolytic pathway have been shown to be required for efficient V-ATPase assembly, most notably aldolase 94 and phosphofructokinase-1. 95 However, the mechanism by which RAVE and any of these enzymes promote the assembled state is not known. suggested that EG3 may be under strain in holo VATPase, and it has been proposed that this "springloading" of EG3 that occurs upon assembly of the complex could play a role in the disassembly process by preventing re-association of C foot with a NT(distal) once the interaction is broken at the initiation of the process [ Fig. 5(B) , blue arrow].
Mechanistic model for V-ATPase dissociation. From recent structural and biochemical work, we now know what some of the conformational changes are that take place during regulated V-ATPase disassembly. From the observations that autoinhibited V o is arrested in rotational state 3, the same state that was the least populated in the cryoEM analysis of the holo enzyme, 45 it has been speculated that disassembly occurs when V-ATPase goes through this state during turnover. 26 In our current working model [ Fig. 6 , Supporting Information Fig. S1 ], we therefore assume that disassembly starts when holo V-ATPase is in the catalytic dwell in state 3 [ Fig. 6(A) ]. Once the (as yet unknown) signal for disassembly is received, the ternary interface EG2-a NT(distal) -C foot is broken, allowing a NT to bind to subunit d [ Fig. 6(B) ]. This in turn breaks the H CTa NT interaction and frees up H CT . Since ScV 1 is found to be arrested in state 2, DF has to rotate two 120 steps at the expense of the hydrolysis of two MgATP molecules [ Fig. 6(C, D) ]. As V o remains in state 3, this would require uncoupling of the V 1 central DF rotor from the d subunit. Once V 1 is in state 2, MgADP inhibition sets in and A 3 B 3 DF presents a high-affinity binding site for H CT [ Fig. 6(E) ]. Note that subunit C is released during this process, possibly because of the conformational changes in EG3 induced by the two steps of ATP hydrolysis. Since most of the weak interactions are now broken, the complex is destabilized to a point so that disassembly could occur [ Fig. 6(F) ]. It should be pointed out that the timing of the structural changes, a NT binding to d and H CT binding to A 3 B 3 DF [ Fig. 6(G, H) ] has not been firmly established. Furthermore, whether the final dissociation step [ Fig. 6(F) ] occurs right away or whether the weak affinity of some of the residual interactions keeps the V 1 transiently attached to the membrane in vivo has been debated based on in vivo fluorescence and FRET imaging. 99 Conclusions and the "To-Do" List While our understanding of the structure and regulatory mechanism of the vacuolar ATPase is better than ever before, more information leads to new questions and there is still much work to be done. Most pressing is the need for high-resolution structural information for the active holo V-ATPase and its autoinhibited V 1 and V o sectors, information that will be essential for our understanding of the proton-pumping and regulatory mechanisms of the enzyme. However, V-ATPase is a dynamic nano-motor that races through many conformations during its catalytic and regulatory cycle, and structural information alone will not suffice to uncover V-ATPase's many remaining secrets.
Currently, the highest resolution information available is for the autoinhibited V o from yeast. 48,96,97 (B) Spring-loading of EG3. It has been suggested that the tension in EG3 would prevent re-forming of the EG2-a NT(distal) -C foot ternary interface after one of these interactions is broken to initiate disassembly. 49 However, whether the interactions between a CT and the c-ring seen in V o are the same as in state 3 holo V 1 V o , and how the ring interacts with a CT 's essential arginine in the remaining states 1 and 2 remains to be seen. Also unresolved is the question whether V o autoinhibition is caused solely by the asymmetric spacing of the proton carrying glutamates in the c-ring, or whether the conformational change in a NT upon enzyme disassembly is transmitted to a CT to help block the proton channel? Static structures must be complemented with functional studies to resolve remaining mechanistic questions, including, how does the proteolipid ring interact with residues in a CT during rotation, and how do these interactions result in net transport of protons? Does the asymmetry in the angular steps of the proton carrying glutamates in the c-ring serve primarily for autoinhibition of free V o , or does the asymmetry also function to inhibit reverse rotation in holo V 1 V o ? What is the molecular signal for enzyme dissociation, and how does this signal cause breaking of protein-protein interactions at the V 1 -V o interface, in particular the high-affinity interaction between subunit C and peripheral stalk EG3? Where does subunit C go upon release from V 1 and V o , and does the binding and/or release of C involve post-translational modifications? What is the order of the functional events (e.g. MgADP inhibition) and structural changes (movements of H CT and EG3 in V 1 and a NT in V o ) that occur during enzyme dissociation? Is MgADP inhibition a prerequisite for enzyme disassembly? Conversely, what is the signal (or signals) that lead to reassembly, and what role do assembly chaperones such as the RAVE complex play in the process? Do the assembly chaperones merely serve to bring the components back together, or does the RAVE complex also function to overcome the conformational mismatch between state 2 V 1 and state 3 V o ? Furthermore, there is mounting evidence that V o , possibly via its proteolipid ring, participates in cellular functions other than proton pumping such as membrane fusion and neuronal communication. [100] [101] [102] However, the significance of these socalled "noncanonical" functions of the free V o are only beginning to emerge. Finally, aberrant VATPase function is involved in many widespread human diseases. Therefore, the ultimate question is how we can apply our present knowledge and insights from future structural and functional studies to aid in the design of therapeutics to fight against human disease, with one attractive possibility being the targeting of reversible disassembly of the human V-ATPase in an isoform and tissue specific manner.
